Signet Financial Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Signet Financial Management's DGX Position: Q1 2022 in Review
Signet Financial Management sold out of Quest Diagnostics (DGX) in Q1 2022, closing a stake of 283 shares — an estimated $49K sold.
Signet Financial Management first reported a position in DGX in Q4 2014 and held it in 17 quarters. The position peaked at $8.06M in Q2 2017. 851 funds tracked by Wall St. Rank hold DGX as of Q1 2022.
- Signet Financial Management reported no remaining Quest Diagnostics position as of Q1 2022 after selling out during the quarter.
- Signet Financial Management sold 283 Quest Diagnostics shares in Q1 2022, an estimated $49K.
- Signet Financial Management first reported a position in Quest Diagnostics in Q4 2014 and held it in 17 quarters.
- Signet Financial Management's Quest Diagnostics position peaked at $8.06M in Q2 2017.
- 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.
Based on Signet Financial Management's 13F filing for Q1 2022, filed 13 May 2022.